Efficacy of Coronary Sinus Pacing for Cardiogenic Shock Due to Percutaneous Coronary Intervention-induced Sick Sinus

Shun Yokota1, Nobuaki Igarashi1, Tomofumi Doi1

  • 1Division of Cardiovascular Medicine, Department of Internal Medicine, Japanese Red Cross Kobe Hospital, Japan.

Insights

Atrial pacing with coronary sinus pacing can stabilize hemodynamics in patients with sick sinus syndrome (SSS) after percutaneous coronary intervention (PCI). This combined approach proved effective when ventricular pacing alone failed to manage cardiogenic shock.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Interventional Cardiology

Background:

  • Sick sinus syndrome (SSS) can cause hemodynamic instability and cardiogenic shock.
  • Percutaneous coronary intervention (PCI) can sometimes induce SSS due to complications like impaired sinus node artery (SNA) blood flow.
  • Ventricular pacing alone may be insufficient to manage SSS-induced hemodynamic compromise.

Observation:

  • Two cases presented with cardiogenic shock and SSS post-PCI.
  • The SSS was attributed to compromised SNA flow, with a stent jailed across the lesion.
  • Initial management with ventricular pacing alone did not adequately stabilize hemodynamics.

Findings:

  • Combined atrial pacing and coronary sinus (CS) pacing successfully improved hemodynamic instability in both cases.
  • This dual-pacing strategy effectively addressed the challenges posed by SSS when ventricular pacing was inadequate.
  • The findings suggest a potential benefit of adding atrial pacing to CS pacing in specific SSS scenarios.

Implications:

  • Atrial pacing combined with CS pacing may be a valuable therapeutic option for managing hemodynamic instability in PCI-induced SSS.
  • This approach could offer an alternative or adjunct to standard pacing in complex cases of SSS.
  • Further research is warranted to explore the broader applicability and long-term efficacy of this combined pacing strategy.

Related Concept Videos

ECG Interpretation of Arrhythmias I: Sinus Arrhythmias01:16

ECG Interpretation of Arrhythmias I: Sinus Arrhythmias

Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism, and...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...